These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 31949479)

  • 1. Pan-cancer analysis of
    Jiang T; Chen X; Su C; Ren S; Zhou C
    J Cancer; 2020; 11(4):776-780. PubMed ID: 31949479
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of ARID1A as a Potential Biomarker for Predicting Response to Immune Checkpoint Inhibitors in Patients with Endometrial Cancer.
    Yamashita H; Nakayama K; Kanno K; Ishibashi T; Ishikawa M; Iida K; Razia S; Kiyono T; Kyo S
    Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect and biomarker of immune checkpoint blockade therapy for ARID1A deficiency cancers.
    Wang L; Qu J; Zhou N; Hou H; Jiang M; Zhang X
    Biomed Pharmacother; 2020 Oct; 130():110626. PubMed ID: 32791396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dramatic Response to Pembrolizumab Monotherapy in a Patient With ARID1A-Mutant Lung Adenocarcinoma: Case Report.
    Harada G; Amano MT; Antonacio FF; Behar MH; Nabuco-de-Araujo PHX; Buchpiguel CA; Junior GC
    Clin Lung Cancer; 2021 Sep; 22(5):e708-e711. PubMed ID: 33658161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of multiple parameters associated with tumor immune microenvironment in
    Li Z; Lin J; Zhang L; Li J; Zhang Y; Zhao C; Wang H
    Future Oncol; 2020 Oct; 16(29):2295-2306. PubMed ID: 32639175
    [No Abstract]   [Full Text] [Related]  

  • 6.
    Li L; Li M; Jiang Z; Wang X
    Cells; 2019 Jul; 8(7):. PubMed ID: 31277418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Establishment of a mutation prediction model for evaluating the efficacy of immunotherapy in renal carcinoma].
    Qin CP; Song YX; Ding MT; Wang F; Lin JX; Yang WB; DU YQ; Li Q; Liu SJ; Xu T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):663-668. PubMed ID: 35950389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade.
    Shen J; Ju Z; Zhao W; Wang L; Peng Y; Ge Z; Nagel ZD; Zou J; Wang C; Kapoor P; Ma X; Ma D; Liang J; Song S; Liu J; Samson LD; Ajani JA; Li GM; Liang H; Shen X; Mills GB; Peng G
    Nat Med; 2018 May; 24(5):556-562. PubMed ID: 29736026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of immunotherapy in ARID1A-mutant solid tumors: a single-center retrospective study.
    Zhou H; Sun D; Song S; Niu Y; Zhang Y; Lan H; Cui J; Liu H; Liu N; Hou H
    Discov Oncol; 2024 Jun; 15(1):213. PubMed ID: 38847966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
    Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
    JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ARID1A deficiency associated with MMR deficiency and a high abundance of tumor-infiltrating lymphocytes predicts a good prognosis of endometrial carcinoma.
    Sun D; Zhao H; Zhou H; Tao J; Li T; Zhu J; Hou H
    Transl Oncol; 2023 Jul; 33():101685. PubMed ID: 37137217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor mutational burden as a predictive biomarker for checkpoint inhibitor immunotherapy.
    Lee M; Samstein RM; Valero C; Chan TA; Morris LGT
    Hum Vaccin Immunother; 2020; 16(1):112-115. PubMed ID: 31361563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers for Response of Melanoma Patients to Immune Checkpoint Inhibitors: A Systematic Review.
    Jessurun CAC; Vos JAM; Limpens J; Luiten RM
    Front Oncol; 2017; 7():233. PubMed ID: 29034210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-1/PD-L1 Blockade Therapy in Advanced Non-Small-Cell Lung Cancer: Current Status and Future Directions.
    Xia L; Liu Y; Wang Y
    Oncologist; 2019 Feb; 24(Suppl 1):S31-S41. PubMed ID: 30819829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Value of Max's Giant Associated Protein Mutation in Outcomes of Lung Adenocarcinoma Patients Treated With Immune Checkpoint Inhibitors.
    Qu Y; Wang C; Liu L; Li S; Zhang X; Ma Z; Bai H; Wang J
    Front Cell Dev Biol; 2021; 9():728647. PubMed ID: 34733843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ARID1A-deficiency in urothelial bladder cancer: No predictive biomarker for EZH2-inhibitor treatment response?
    Garczyk S; Schneider U; Lurje I; Becker K; Vögeli TA; Gaisa NT; Knüchel R
    PLoS One; 2018; 13(8):e0202965. PubMed ID: 30138427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the alterations of ARID1A in pancreatic cancer: tumorigenesis, prediction of treatment, and prognostic value.
    Li R; Xiong G; Zhao J; Yang L
    Am J Transl Res; 2022; 14(9):5952-5964. PubMed ID: 36247295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers, measured during therapy, for response of melanoma patients to immune checkpoint inhibitors: a systematic review.
    Ouwerkerk W; van den Berg M; van der Niet S; Limpens J; Luiten RM
    Melanoma Res; 2019 Oct; 29(5):453-464. PubMed ID: 30855527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous expression of ARID1A in colorectal cancer indicates distinguish immune landscape and efficacy of immunotherapy.
    Guan X; Cui L; Ruan Y; Fang L; Dang T; Zhang Y; Liu C
    Discov Oncol; 2024 Mar; 15(1):92. PubMed ID: 38555560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDAC6 Inhibition Synergizes with Anti-PD-L1 Therapy in ARID1A-Inactivated Ovarian Cancer.
    Fukumoto T; Fatkhutdinov N; Zundell JA; Tcyganov EN; Nacarelli T; Karakashev S; Wu S; Liu Q; Gabrilovich DI; Zhang R
    Cancer Res; 2019 Nov; 79(21):5482-5489. PubMed ID: 31311810
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.